EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro
- PMID: 9052984
EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro
Abstract
Among primitive neuroectodermal tumors, Ewing tumors are characterized by a gene rearrangement recombining the 5'-EWS gene portion with one of two ETS-related proto-oncogenes, FLI-1 or ERG, in roughly 90 and 10% of cases, respectively. We attempted to antagonize EWS/FLI-1 function in Ewing tumor cell lines. As a control, a cell line derived from another small round cell tumor of neuroectodermal origin, neuroblastoma, was used. This cell line was found to express almost identical patterns of ETS proteins except for EWS/FLI-1 and a novel, ELF-related gene product. Stable expression of antisense EWS/FLI-1 cDNA resulted in decreased endogenous EWS/FLI-1 RNA levels and growth reduction of ET cells but not of neuroblastoma cells. DNA-binding FLI-1 derivatives localizing to the nucleus in which the 5'-EWS regulatory domain was replaced by bacterial beta-galactosidase dominantly modulated transcriptional transactivation from a degenerate ETS-binding motif. Transient transfection of these dominant-negative recombinants resulted in a significant decrease in the relative number of mitoses in four Ewing tumor cell lines tested but not in the neuroblastoma cell line. The presented evidence for modulation of tumor cell proliferation by EWS/FLI-1 antagonists suggests a causal role for EWS/FLI-1-mediated gene activation in the malignant transformation of the enigmatic Ewing tumor-precursor cell.
Similar articles
-
Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.Oncogene. 2003 Jan 9;22(1):1-9. doi: 10.1038/sj.onc.1206055. Oncogene. 2003. PMID: 12527902
-
A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG.Nat Genet. 1994 Feb;6(2):146-51. doi: 10.1038/ng0294-146. Nat Genet. 1994. PMID: 8162068
-
Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.Nat Genet. 1999 Oct;23(2):222-7. doi: 10.1038/13854. Nat Genet. 1999. PMID: 10508522
-
The ETS oncogene family in development, proliferation and neoplasia.Int J Hematol. 1994 Jun;59(4):257-65. Int J Hematol. 1994. PMID: 8086619 Review.
-
Context matters: the hen or egg problem in Ewing's sarcoma.Semin Cancer Biol. 2005 Jun;15(3):189-96. doi: 10.1016/j.semcancer.2005.01.004. Semin Cancer Biol. 2005. PMID: 15826833 Review.
Cited by
-
Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model.Oncotarget. 2017 May 23;8(21):34141-34163. doi: 10.18632/oncotarget.9388. Oncotarget. 2017. PMID: 27191748 Free PMC article.
-
Chemotherapy in Ewing's sarcoma.Indian J Orthop. 2010 Oct;44(4):369-77. doi: 10.4103/0019-5413.69305. Indian J Orthop. 2010. PMID: 20924476 Free PMC article.
-
Regulation of EWSR1-FLI1 Function by Post-Transcriptional and Post-Translational Modifications.Cancers (Basel). 2023 Jan 6;15(2):382. doi: 10.3390/cancers15020382. Cancers (Basel). 2023. PMID: 36672331 Free PMC article. Review.
-
Children's Oncology Group's 2023 blueprint for research: Bone tumors.Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30583. doi: 10.1002/pbc.30583. Epub 2023 Jul 27. Pediatr Blood Cancer. 2023. PMID: 37501549 Free PMC article.
-
Circulating Plasma Tumor DNA Is Superior to Plasma Tumor RNA Detection in Ewing Sarcoma Patients: ptDNA and ptRNA in Ewing Sarcoma.J Mol Diagn. 2021 Jul;23(7):872-881. doi: 10.1016/j.jmoldx.2021.04.003. Epub 2021 Apr 20. J Mol Diagn. 2021. PMID: 33887462 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials